Skip to main content
Skip to main content
Back to Grand Rounds
Grand RoundsWeekly Evidence Brief

Preventive Medicine

Edition
Latest

30-Second Takeaway

  • Patient decision aids can improve risk perception and knowledge but may not increase informed prevention choices.
  • Brief parenting interventions may reduce total abuse reports and improve child mental health over 2.5 years.

Latest - Week ending July 4, 2026

Five recent studies with direct implications for preventive medicine practice

Decision support improved knowledge but not informed chemoprevention choice in high-risk women

JOURNAL OF THE NATIONAL CANCER INSTITUTEJul 2, 2026

In a 31-site cluster randomized trial of 412 enrolled high-risk women, a patient decision aid plus provider tool did not increase informed chemoprevention choice at 6 months (35% vs 27%, p=0.20) or 12 months (37% vs 25%, p=0.05). At 6 months the intervention improved accurate breast cancer risk perception (31% vs 21%, p=0.03) and chemoprevention knowledge (33% vs 23%, p=0.04). Self-reported chemoprevention initiation at 12 months was similar between arms (50% intervention, 52% control). Interpretation: decision support yields modest cognitive benefits but did not translate into greater informed choice in this trial.

Families value recommendations and report high involvement in pediatric precision-medicine trials

NPJ GENOMIC MEDICINEJul 4, 2026

In the PRISM precision-medicine trial, most parents and adolescent patients expected benefit (87%) and a treatment recommendation (68%) at enrollment. Seventy percent of parents received a recommendation but only about half recalled it afterwards. Parents reported high involvement (93/100) and high satisfaction (95/100) with treatment decisions, and receipt of a recommendation was not linked to regret. Interpretation: families derive hope and perceived value from recommendations, but recall is limited and expectation management is important.

Protocol: LLM-driven text coaching trial embedded in a large digital cardiovascular biobank

AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGYJul 3, 2026

This protocol describes a prospective digital cohort aiming to enroll 15,000 adults with an embedded randomized crossover trial of LLM-generated versus generic text coaching to increase daily steps. Primary outcome is change in daily step count, with secondary outcomes including active minutes, calorie burn, fitness tests, and sensor-derived biomarkers linked to EHR outcomes. The design emphasizes cross-platform scalability, passive sensor data capture, and integration with HL7 FHIR for longitudinal outcomes. Interpretation: this is a scalable prevention model but currently a protocol—effectiveness and safety of LLM coaching remain to be shown.

References

Numbered in order of appearance. Click any reference to view details.

Additional Reads

Optional additional studies from this edition.

Edition context

Clinical signal

  • Monitor uptake versus measured informed choice when using decision aids; specialist setting may increase uptake.
  • In pediatric precision trials, expect high parental hope and satisfaction but verify recall of recommendations.
  • Treat digital LLM-driven coaching protocols as protocolized interventions until effectiveness data are available.